Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
07/13/2011 | CN102119938A Folk Chinese herb medicine fruiting eight trigram-shaped maple root wine |
07/13/2011 | CN102119929A Medicinal composition of sulbenicillin sodium for injection and preparation method thereof |
07/13/2011 | CN102119924A Monodisperse nano aztreonam liposome preparation and preparation method thereof |
07/13/2011 | CN102119923A Antibiotic oil-water double suspension type injection emulsion for livestock and preparation method thereof |
07/13/2011 | CN102119921A Aivlosin injection for swine and preparation method thereof |
07/13/2011 | CN102119919A Preparation method of valnemulin oily injection |
07/13/2011 | CN101721378B Method for preparing cefmenoxime hydrochloride freeze-dried powder injection |
07/13/2011 | CN101716142B Nimesulide injection for livestock and preparation method thereof |
07/13/2011 | CN101648929B Lignanoid-like compound contained in cabo and preparation method and application thereof |
07/13/2011 | CN101584702B Method of preparing extract of Mallotus apelta and uses for fighting hepatitis B virus |
07/13/2011 | CN101531637B A novel compound capable of restraining and blocking M2 ion channel activity and application thereof |
07/13/2011 | CN101518644B Application of Ang-2 and genes thereof in pharmacy |
07/13/2011 | CN101440098B Crystal of oxacephem |
07/13/2011 | CN101342229B Composition of Canton love-pea vine extract, preparation method and pharmaceutical use |
07/13/2011 | CN101306126B Quality control method of compound south isatis root granules |
07/13/2011 | CN101220002B Oxazolidinone compound as antimicrobial |
07/12/2011 | US7977477 Benzimidazole derivatives and their use as protein kinase inhibitors |
07/12/2011 | US7977349 Substituted quinolones III |
07/12/2011 | US7977330 Salts and crystal modifications thereof |
07/12/2011 | US7977327 Substituted pyrrolidine derivative |
07/12/2011 | US7977047 Delete sequence in M. tuberculosis, method for detecting mycobacteria using these sequences and vaccines |
07/12/2011 | US7976870 using a sustained release oral dosage form of a therapeutically effective amount of the drug such as minocycline hydrochloride incorporated in a matrix of biocompatible, hydrophilic polymer of specified swelling properties and erosion rate |
07/12/2011 | US7976849 Hepatitis-C virus testing |
07/12/2011 | US7976846 Stress protein complex; a grp170 polypeptide and an immunogenic polypeptide; antitumor |
07/12/2011 | US7976844 Fusion proteins of Mycobacterium tuberculosis |
07/12/2011 | US7976843 Method for screening peptides for use in immunotherapy |
07/12/2011 | CA2588398C Potassium salt of an hiv integrase inhibitor |
07/12/2011 | CA2517629C Phthalazinone derivatives |
07/12/2011 | CA2516699C Hiv replication inhibiting pyrimidines and triazines |
07/12/2011 | CA2497167C Modified saccharides, conjugates thereof, and their manufacture |
07/12/2011 | CA2481767C Severe sepsis preventive therapeutic agent |
07/12/2011 | CA2480162C Induction of anti-tumor ctl immunity through in vivo triggering of 4-1bb and/or cd40 |
07/12/2011 | CA2463616C Affinity enhancement agents |
07/12/2011 | CA2463505C Low-calcemic oxime analogs of 1.alpha.,25-dihydroxy vitamin d3 |
07/12/2011 | CA2458455C Pharmaceutical compositions comprising colloidal silicon dioxide |
07/12/2011 | CA2457528C Rna interference mediated inhibition of hepatitis c virus (hcv) gene expression using short interfering nucleic acid (sina) |
07/12/2011 | CA2449150C Tricyclic compounds useful as angiotensin ii agonists |
07/12/2011 | CA2435611C Alpha-amino-n-hydroxy-acetamide derivatives |
07/12/2011 | CA2419148C Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods |
07/12/2011 | CA2405438C Hepatitis b core antigen fusion proteins |
07/12/2011 | CA2397347C Factor vii or viia-like molecules |
07/12/2011 | CA2393312C Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
07/12/2011 | CA2389685C Novel heterocyclic compounds and their use as medicaments |
07/12/2011 | CA2351712C Crystal modification a of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid |
07/12/2011 | CA2341336C Elongase genes and uses thereof |
07/12/2011 | CA2329133C Recombinant venezuelan equine encephalitis virus vaccine |
07/12/2011 | CA2182976C Active immunization using a siderophore receptor protein |
07/07/2011 | WO2011082422A2 Human immunodeficiency virus (hiv-1) highly conserved and low variant sequences as targets for vaccine and diagnostic applications |
07/07/2011 | WO2011082400A2 Modulators of immunoinhibitory receptor pd-1, and methods of use thereof |
07/07/2011 | WO2011082331A2 Compositions and methods for treating hepatitis b virus infection |
07/07/2011 | WO2011082289A1 Cyclosporine analogues |
07/07/2011 | WO2011082077A1 Hepatitis c virus inhibitors |
07/07/2011 | WO2011081765A1 Pythium immunotherapy |
07/07/2011 | WO2011081612A1 Use of krypton or xenon as an antiviral agent |
07/07/2011 | WO2011081523A1 Interferon analogs |
07/07/2011 | WO2011081173A1 Tetracyclic compound |
07/07/2011 | WO2011081083A1 Neuraminic acid derivative, sialidase activity inhibitor and antiinfluenza drug |
07/07/2011 | WO2011080691A1 Method for the production of amorphous rifaximin |
07/07/2011 | WO2011080562A1 Novel aza-peptides containing 2,2-disubstituted cyclobutyl and/or substituted alkoxy benzyl derivatives as antivirals |
07/07/2011 | WO2011080266A1 New secondary 8-hydroxyquinoline-7-carboxamide derivatives. |
07/07/2011 | WO2011080265A1 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents |
07/07/2011 | WO2011080264A1 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof |
07/07/2011 | WO2011080259A1 Lipopeptide- and lipoprotein-conjugates and its use |
07/07/2011 | WO2011079969A1 A 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative for pharmaceutical use, and the use of a 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative with substantially undefined crystal shape for preparing said 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative |
07/07/2011 | WO2011079627A1 Multi-component adjuvant of immersion vaccine for fish, and its application and using method |
07/07/2011 | WO2011079501A1 Prodrug based on cytarabine structure as well as synthesizing method and application thereof |
07/07/2011 | WO2011079349A1 Okadaella gastrococcus and cancer |
07/07/2011 | WO2011008092A4 Gram-positive bacteria specific binding compounds |
07/07/2011 | WO2011005044A9 Novel strain of streptomyces sporoclivatus which suppresses ginseng root rot |
07/07/2011 | WO2010091373A8 Trimeric hiv fusion inhibitors for treating or preventing hiv infection |
07/07/2011 | WO2010057275A8 Cyclic peptides and uses thereof |
07/07/2011 | US20110167512 Hybrid artichoke variety nun 4006 ar |
07/07/2011 | US20110166320 Somatostatin analogues |
07/07/2011 | US20110166218 Methods for micronization of hydrophobic drugs |
07/07/2011 | US20110166207 Use of aav integration efficiency element for mediating site-specific integration of a transcription unit |
07/07/2011 | US20110166179 Antibacterial quinoline derivatives |
07/07/2011 | US20110166175 7-azaindole derivatives |
07/07/2011 | US20110166173 3,5-disubstututed 1h-pyrrolo [2,3-b] pyridines as jnk inhibitors |
07/07/2011 | US20110166169 Novel hsp90 inhibitory carbazole derivatives, compositions containing same and use thereof |
07/07/2011 | US20110166164 THIAZOLO[5,4-d] PYRIMIDINES AND THEIR USE AS AGROCHEMICALS |
07/07/2011 | US20110166147 Imidazopyrazine compounds |
07/07/2011 | US20110166131 Substituted pyrrolidine derivative |
07/07/2011 | US20110166123 Novel compositions and methods of use |
07/07/2011 | US20110166119 Synergistic Combinations of Aztreonam with the Carbapenems Meropenem and Ertapenem |
07/07/2011 | US20110166118 New trinem antibiotics and inhibitors of beta-lactamases |
07/07/2011 | US20110166112 Method for stimulating platelet production |
07/07/2011 | US20110166110 Fused Ring Azadecalin Glucocorticoid Receptor Modulators |
07/07/2011 | US20110166108 Methods of use related to xerostomia |
07/07/2011 | US20110166106 Artemisinin and derivatives thereof as antivirals |
07/07/2011 | US20110166103 Boron-containing small molecules |
07/07/2011 | US20110166102 Novel 2-substituted benzimidazoles as selective androgen receptor modulators (sarms) |
07/07/2011 | US20110166092 Dosing methods for treating disease |
07/07/2011 | US20110166091 Compositions Containing Piperacillin and Tazobactam Useful for Injection |
07/07/2011 | US20110166088 Benzothiazoles and aza-analogues thereof use as antibacterial agents |
07/07/2011 | US20110166087 Pharmaceutical composition for use in treating sexually transmitted infections |
07/07/2011 | US20110166061 Long lasting fusion peptide inhibitors for hiv infection |
07/07/2011 | US20110166058 Organic compositions to treat hsf1-related diseases |
07/07/2011 | US20110165653 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
07/07/2011 | US20110165633 Production of Polyketides and Other Natural Products |
07/07/2011 | US20110165266 Screen for inhibitors of hiv replication |